HARMON CYRUS (Chief Technology Officer) sold 1.4% of their position (10K shares) of OLEMA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $268.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/21/2026ACC: 0001831410-26-000004
DirectorOfficer· Chief Technology Officer
Since Nov 2020
-10K
Net shares
Net seller
$268.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10K
Price / share
$26.88
Trade value
$268.80K
% of position
1.4%
1/20/2026
737.77K→727.77K
Total
Net shares
−10K
Net value
-$268.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/20/2026 | S · Sale | −10K | $26.88 | $268.80K | 1.4% | 737.77K | 727.77K |
| Total | −10K | -$268.80K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned117.03K
Total
117.03K indirect117.03K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 117.03K | Indirect |
| Total | 117.03K | 117.03K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported